American Journal of Epidemiology Vol. 115, No. 5: 657-663
Copyright © 1982 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
PLASMA LIPIDS AND DIABETES MELLITUS IN AN ADULT COMMUNITY
1Departments of Community and Family Medicine and Medicine School of Medicine, University of California, San Diego, CA
2Center for Human Nutrition University of Texas, Dallas, TX
3Lipid Research Clinic, University of California San Diego, CA
Reprint requests to Dr. Barrett-Connor, Department of Community and Family Medicine M-007, University of California, San Diego, CA 92093
Most previous studies of hyperilpidemia in diabetics are based on patients in specialty clinics or reflect an era when diabetics consumed a high-fat, low-carbohydrate diet. In this paper, data from a defined adult population aged 20–79 years in an upper middle class community in Southern California, 1972–1974, were used to ascertain the relationship of hyperlipidemia to diabetes in a current community-based population. All (n = 358) diabetics defined by history and/or fasting hyperglycemia (fasting plasma glucose, 
140 mg/dl) were compared with all (n = 4387) nondiabetlcs defined as euglycemic (fasting plasma glucose, < 110 mg/dl) with no personal or family history of diabetes. In both men and women 50 years of age and older, the mean cholesterol level and the prevalence of categorical hypercholesterolemia were not significantly different in diabetics vs. nondiabetics, whereas the mean triglyceride level and the prevalence of categorical hypertriglyceridemia were significantly higher in diabetics vs. nondiabetics. Case-control comparisons of 356 diabetics matched for age and obesity with 356 nondiabetics confirmed the significantly higher triglyceride levels in diabetes. Conversely, hypertriglyceridemia was associated with diabetes in 29 per cent of nonobese men and 25 per cent of obese men, and in 10 per cent of non-obese women and 21 per cent of obese women. The biologic mechanism of hypertriglyceridemia in diabetics is discussed.
cholesterol; diabetes mellitus; hyperlipidemia; obesity; triglycerides
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. C. Tong, A. P. Kong, W.-Y. So, X. Yang, C.-S. Ho, R. C. Ma, R. Ozaki, C.-C. Chow, C. W. Lam, J. C.N. Chan, et al. The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 Diabetes Diabetes Care, May 1, 2007; 30(5): 1206 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Chiu, A. Kovacs, R. M. Blanton, X. Han, M. Courtois, C. J. Weinheimer, K. A. Yamada, S. Brunet, H. Xu, J. M. Nerbonne, et al. Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy Circ. Res., February 4, 2005; 96(2): 225 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ferrara, D. F. Williamson, A. J. Karter, T. J. Thompson, C. Kim, and for the TRIAD Study Group Sex Differences in Quality of Health Care Related to Ischemic Heart Disease Prevention in Patients With Diabetes: The Translating Research Into Action for Diabetes (TRIAD) study, 2000-2001 Diabetes Care, December 1, 2004; 27(12): 2974 - 2976. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe Women and Heart Disease: The Role of Diabetes and Hyperglycemia Arch Intern Med, May 10, 2004; 164(9): 934 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vijan and R. A. Hayward Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians Ann Intern Med, April 20, 2004; 140(8): 650 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Valabhji and R. S Elkeles Dyslipidaemia in type 2 diabetes: epidemiology and biochemistry The British Journal of Diabetes & Vascular Disease, May 1, 2003; 3(3): 184 - 189. [Abstract] [PDF]
|
|
|
|
|
|
W. Lu, H. E. Resnick, K. A. Jablonski, K. L. Jones, A. K. Jain, Wm. J. Howard, D. C. Robbins, and B. V. Howard Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes: The Strong Heart Study Diabetes Care, January 1, 2003; 26(1): 16 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Barrett-Connor Sex Differences in Coronary Heart Disease: Why Are Women So Superior? The 1995 Ancel Keys Lecture Circulation, January 7, 1997; 95(1): 252 - 264. [Full Text]
|
|
|
|
 |
|
 E. L. Barrett-Connor, B. A. Cohn, D. L. Wingard, and S. L. Edelstein Why Is Diabetes Mellitus a Stronger Risk Factor for Fatal Ischemic Heart Disease in Women Than in Men? The Rancho Bernardo Study JAMA, February 6, 1991; 265(5): 627 - 631. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Grundy Cholesterol and Coronary Heart Disease: Future Directions JAMA, December 19, 1990; 264(23): 3053 - 3059. [Abstract] [PDF]
|
|
|
|
|
|
G. Steiner From an Excess of Fat, Diabetics Die JAMA, July 21, 1989; 262(3): 398 - 399. [Abstract] [PDF]
|
|